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Attention performance among 
Brazilian truck drivers and its 
association with amphetamine 
use: pilot study
Desempenho da atenção entre 
motoristas de caminhão brasileiros 
e sua associação com uso de 
anfetaminas: estudo-piloto
ABSTRACT
The aim of this article was to describe the attention functioning of twenty-two 
truck drivers and its relationship with amphetamine use. Those drivers who 
reported using amphetamines in the twelve months previous to the interview 
had the best performance in a test evaluating sustained attention functioning. 
Although amphetamine use may initially seem advantageous to the drivers, 
it may actually impair safe driving. The findings suggest the importance of 
monitoring the laws regarding amphetamine use in this country.
DESCRIPTORS: Automobile Driving. Motor Vehicles. Amphetamines, 




O objetivo deste estudo foi descrever o desempenho de atenção de motoristas de 
caminhão e sua relação com o uso de anfetaminas. Os motoristas que relataram 
usar anfetaminas nos doze meses prévios à entrevista tiveram desempenho 
melhor em um teste de atenção sustentada. Apesar de inicialmente representar 
uma vantagem para motoristas, o uso de anfetaminas pode dificultar a direção 
segura. Os resultados sugerem a importância de supervisionar as leis que 
regulamentam o uso de anfetaminas no País.
DESCRITORES: Condução de Veículo. Veículos Automotores. 
Anfetaminas, efeitos adversos. Análise e Desempenho de Tarefas. 
Transportes, recursos humanos. Estudos Transversais.
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Road traffic injuries remain an important public health 
issue worldwide.10 More than 1.24 million people die 
each year because of road traffic crashes and 20 to 
50 million are estimated to be injured.10 This health 
burden of epidemic proportions can be considered an 
increasing problem, particularly in middle-income 
countries.10 The road traffic fatality rate in Brazil is 
18.3/100,000 inhabitants.11
Several risk factors are associated with traffic accidents, 
of which drug use needs special attention.11 The use of 
amphetamine-type stimulants (ATS) has been increasing 
in the last few years, especially for occupational 
purposes, due to their performance-enhancing effects.a
Truck drivers in Brazil have reported the illicit use of 
amphetamines to focus their attention and stay awake 
longer to maintain their extensive work schedule.1
Despite the amphetamine use (AU) by truck drivers 
being widely acknowledged in Brazil, little is known 
about its effects on attention functioning.
In consistency with the findings of the abovemen-
tioned studies on the underlying reasons for AU 
among truck drivers, it may improve the individual’s 
attention performance.
This study aimed to describe attention functioning 
among truck drivers and its relationship with amphet-
amine use.
METHODS
This is the pilot study of an ongoing project.b A conve-
nience sample consisting of 22 truck drivers was 
recruited in the Presidente Dutra highway at the (Serviço 
Social do Transporte – SEST; and Serviço Nacional de 
Aprendizagem do Transporte – SENAT) service station, 
in Sao Paulo, Southeastern Brazil, in 2011.
The sample was made up of truck drivers traveling 
along the Presidente Dutra highway who spontaneously 
stopped to use the SEST-SENAT services and agreed 
to participate in the study.
None of the participants reported any conditions that 
might interfere with attention functioning, such as 
previous history of neurological disease, head trauma, 
loss of consciousness, previous sexually transmitted 
disease or HIV infection, recent use of psychotropics, 
and difficulty visualizing colors. Drivers that reported 
any of these conditions were not included in the study.
INTRODUCTION
Participants were requested to answer a structured, 
self-reported anonymous questionnaire about personal 
and occupational data. Drug use was measured for drugs 
most commonly used by truck drivers, i.e., alcohol, 
tobacco, amphetamines, marijuana and cocaine, 
regarding three periods (lifetime, past 12 months, and 
past 30 days).c The frequency and reason underlying the 
use of amphetamine, as well as the last day of amphet-
amine use, were also investigated. Participants agreed 
to provide a urine sample for drug screening. On-Site 
CupKit 501 (Varian) was used for amphetamine, canna-
binoids and cocaine metabolites detection.
Tests that measure selective and sustained attention 
performance were adopted. Selective attention is 
defined as the readiness to selectively identify and 
respond to stimuli to the exclusion of others (irrelevant 
stimuli), while sustained attention refers to the capacity 
to maintain it over a certain period.2
Selective attention functioning was assessed through 
participants’ performance in the Stroop Color Word 
Test, Controlled Oral Word Association Test (COWAT; 
letters F, A and S) and Digit Symbol Substitution Test 
(DSST), described in detail elsewhere.7 Sustained atten-
tion functioning was assessed by participants’ perfor-
mance in the Sustained Attention Test (TACOM),8 
an educational-level test standardized for Brazilian 
licensed drivers, which includes the most commonly 
used traffic signs on Brazilian roads as stimuli. 
Participants were instructed to focus their attention 
on specific target stimuli for 90 seconds.8 Participants’ 
performance was measured according to the number of 
hits (COWAT, DSST and TACOM) or time (Stroop) for 
all tests. The final score on TACOM was individually 
compared with normative data.8
Participants were also evaluated according to their 
quality of sleep through the Pittsburgh Sleep Quality 
Index (PSQI), since sleep deprivation is a common 
outcome in such professionals.6
The 12-month drug use was the measure chosen for 
this study. Truck drivers were divided into two groups 
according to their responses regarding the illicit use of 
amphetamines in the last 12 months preceding the inter-
view: group AU (amphetamine users) and group NAU 
(non-amphetamine users). These groups were compared 
for agreement with personal and occupational data, 
alcohol and other drug use, performance in selective and 
sustained attention tests and according to their perfor-
mance in PSQI. Such comparisons were performed by 
a United Nations Office on Drugs and Crime. Amphetamines and Ecstasy. 2008 Global ATS Assessment. Viena; 2008.
b Project approved by the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP – Research support, Young Researcher Program) 
entitled: “Estudo sobre o uso múltiplo de drogas, funcionamento cognitivo, psíquico, emocional e transtornos do sono entre motoristas de 
caminhão no Estado de São Paulo”, in 2011.
c United Nations Office on Drugs and Crime. World Drug Report 2012. New York: United Nations, 2012.
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Table. Personal and occupational information, drug use, quality of sleep and selective and sustained attention performance of 
truck drivers recruited on an interstate highway. Sao Paulo, Southeastern Brazil, 2011.a (N = 22)
12-month amphetamine use NAU (N = 14) AU (N = 8) Total (N = 22)
Categorical variables % 95%CI % 95%CI % 95%CI pb
Formal education (years) 0.184
4 7.1 0.0;20.6 12.5 0.0;35.4 9.1 0.0;21.1
8 28.6 4.9;52.2 62.5 29.0;96.0 40.9 20.4;61.5
8 to 11 57.1 31.2;83.1 12.5 0.0;35.4 40.9 20.4;61.5
> 11 7.1 0.0;20.6 12.5 0.0;35.4 9.1 0.00;21.1
Civil status 0.669
Single 21.4 0.0;42.9 25.0 0.0;55.0 22.7 5.2;40.2
Married 50.0 23.8;76.2 75.0 44.9;100.0 59.1 38.6;79.6
Living together 14.3 0.0;32.6 0.0 0.0;0.0 9.1 0.0;21.1
Divorced 14.3 0.0;32.6 0.0 0.0;0.0 9.1 0.0;21.1
Ethnicity 0.613
White 64.3 39.2;89.4 83.3 57.5;100.0 70.0 5.9;89.2
Black or Mulatto 35.7 10.6;60.8 16.7 0.0;42.5 30.0 10.9;49.2
12-month alcohol use 64.3 39.2;89.4 87.5 64.6;100.0 72.7 24.1;91.3 0.351
12-month tobacco use 14.3 0.0;32.6 37.5 4.0;71.1 22.3 4.9;39.7 0.309
12-month marijuana use 0.0 0.0;0.0 0.0 0.0;0.0 0.0 0.0;0.0 –
12-month cocaine use 0.0 0.0;0.0 0.0 0.0;0.0 0.0 0.0;0.0 –
12-month crack-cocaine use 0.0 0.0;0.0 12.5 0.0;35.4 4.5 0.0;13.3 0.364
Frequency of amphetamine use 0.150
Rarely – – 0.0 0.0;0.0 – –
Less than once a week – – 28.6 0.6;56.6 – –
Once a week and more – – 42.9 12.2;73.5 – –
Daily – – 28.6 0.6;56.6 – –
Reason for amphetamine use
To stay awake – – 100.0 100.0;100.0 – –
TACOM performance 0.010d
Very poor 100.0 0.0;100.0 50.0 15.4;84.7 81.8 65.7;97.9
Low Average 0.0 0.0;0.0 37.5 4.0;71.0 13.6 0.0;28.0
High Average 0.0 0.0;0.0 12.5 0.0;35.4 4.5 0.0;13.3
Numerical variable Mean 95%CI Mean 95%CI Mean 95%CI pc
Age 40.9 39.0;42.7 37.7 34.0;41.4 40.4 38.8;42.0 0.520
Trajectory (in km) 638.5 437.7;839.2 1,156.7 649.8;1,663.5 698.4 515.3;881.5 0.010d
Travel time (in hours) 11.2 10.4;12.1 14.9 10.9;19.0 11.7 10.8;12.6 0.970
Time in profession (in years) 15.9 3.9;17.9 15.7 12.1;19.4 15.8 14.0;17.5 0.760
Stroop-time A (in seconds) 21.1 17.5;24.8 15.7 13.3;18.0 19.5 16.0;23.0 0.084
Stroop-time B (in seconds) 21.7 19.0;24.5 19.3 18.7;20.0 21.0 18.7;23.3 0.327
Stroop-time C (in seconds) 33.6 28.8;38.4 31.0 24.2;37.8 32.6 28.3;37.0 0.635
COWAT_F (number of words generated) 7.3 4.6;10.0 9.0 6.5;11.5 7.9 5.7;10.1 0.343
COWAT_A (number of words generated) 8.6 5.8;11.3 7.8 5.7;9.8 8.3 6.2;10.4 0.848
COWAT_S (number of words generated) 8.9 7.7;10.0 7.5 4.2;10.9 8.4 6.8;9.9 0.562
DSST (number of hits) 23.3 18.7;27.9 23.4 17.1;29.6 23.3 19.5;27.1 0.811
PSQI 5.3 2.6;8.0 5.5 2.5;8.6 5.4 3.2;7.6 0.849
Most recent-amphetamine use (in days) – – 33.60 0.0;76.9 – – –
AU: amphetamine users; COWAT: Controlled Oral Word Association Test (letters F, A and S); DSST: Digit Symbol Substitution 
Test; NAU: non-amphetamine users; Stroop: Stroop Color Word Test; TACOM: Sustained Attention Test; PSQI: Pittsburgh Sleep 
Quality Index
a Numerical variables are expressed as means (95%CI), and categorical variables are expressed as % (95%CI).
b Fisher’s Exact Test (two-tailed test).
c Mann-Whitney Test (two-tailed test).
d The null hypothesis was rejected at a significance level of p < 0.05.
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the Mann-Whitney test for numerical variables and 
Fisher’s Exact Test for categorical variables using the 
R library survey software. The null hypothesis was 
rejected at a significance level of p < 0.05.
The drivers were invited to participate voluntarily; they 
were not financially compensated for their participation. 
The drivers were requested to read and sign, if in accor-
dance with, a written informed consent form (TCLE). 
The study protocol followed the Declaration of Helsinki 
set of principles and was approved by the Research 
Ethics Committee of the Faculty of Medicine of the 
Universidade de São Paulo (Protocol No. 377/11).
RESULTS
All participants were young men with low levels of 
schooling (81.8% reported to have between eight and 
11 years of formal education). They had an average of 
15.8 years in the profession, had traveled an average 
of 698.4 km and had driven an average of 11.7 hours 
without rest before reaching the data collection location. 
Most of them (68.2%) were married or living with a 
partner, 70% self-reported as white or Caucasians and 
all of them were hired by a transportation company.
About 50.0% of the interviewees reported they had 
tried amphetamines in their lifetime, 36.7% had used 
amphetamines in the previous 12 months and 22.7% 
had used amphetamines in the 30 days previous to the 
interview. Among those who reported using amphet-
amines in the previous 12 months, the last time of use 
was 33.6 days before the interview on average; 71.4% 
of them declared using amphetamines at least once a 
week. All of them reported continuing such use to stay 
awake for a longer period to carry out their occupational 
activities. There were no intergroup (AU x NAU) 
differences regarding alcohol, tobacco, marijuana and 
cocaine use in the last 12 months. None of the tested 
samples were positive for amphetamines, nor for other 
drugs in the drug urine screening, indicating that the 
interviewed truck drivers were not under the acute 
effects of any screened drug.
There were no intergroup differences (AU x NAU) 
according to performance in the selective attention tests 
(COWAT, Stroop and DSST) nor with regards quality 
of sleep (PSQI).
The drivers who reported not having used amphet-
amines (NAU) presented the worst performance 
(p < 0.01) on the sustained attention test (TACOM) 
and 95.4% of the participants performed below the 
average level in TACOM, irrespective of amphetamine 
use, indicating the truck drivers’ difficulty maintaining 
their attention focused for prolonged periods.
Long-haul truck drivers seemed to be more prone to 
reporting AU (p < 0.01), i.e., while NAU drivers reported 
traveling an average of 638.5 km, those who were AU 
had travelled an average of 1,156.7 km.
DISCUSSION
The interviewed truck drivers may be suffering from 
sustained attention deficits, i.e., inadequacy in the 
ability to maintain selective attention for a prolonged 
period, an outcome that seemed to be less frequent 
among amphetamine users.
The ability to selectively detect stimuli is a mecha-
nism that the brain uses to manage the massive influx 
of sensory information into the cortex and to reduce 
distractions from irrelevant inputs.3 A deficit in truck 
drivers’ ability to maintain their selective attention for a 
prolonged period (sustained attention) may raise safety 
and legal issues, since truck drivers often spend several 
hours at the steering wheel, as mentioned above. Driver 
distraction is predictive of driving lapses, errors and 
violations,9 which may culminate in negative outcomes 
such as traffic accidents.
This sustained attention deficit was less frequent among 
amphetamine users, suggesting that amphetamines may 
attenuate or mask it, a finding that is consistent with 
the reason most commonly reported by truck drivers 
for their use of amphetamines, i.e., to stay awake 
longer during their occupational activities, as presented 
here and elsewhere.1 This effect of amphetamines on 
attention seemed to be independent of their acute 
effects on the central nervous system (CNS), since 
none of the urine samples was positively screened for 
amphetamines. The observed outcomes may occur 
due to a chronic use of amphetamines, since most 
of the interviewed truck drivers reported consuming 
amphetamines at least once a week.
There seems to be a positive relationship between blood 
amphetamine concentrations and driving impairment.4 
Amphetamine use may appear to be an advantage for 
truck drivers. However, when the amphetamine stimu-
lant effect ends, the user is subject to fatigue, depression 
and sleepiness, increasing the risk of accidents and other 
negative outcomes in traffic. Nascimento et al5 found 
an association between amphetamines use by truck 
drivers and traffic accidents in Brazil. Those drivers 
are likely to develop drug abuse and dependence, and 
to suffer intercurrences.a Hence, the onus of amphet-
amine use is much bigger than the apparent advantage 
of increased attention for a longer period and it should 
therefore be avoided by truck drivers and policed by 
competent authorities.
Considering that road traffic accidents are a predict-
able and preventable cause of deaths and injuries,10 the 
outcomes of this study should help public authorities to 
enforce Laws that regulate the work schedule of truck 
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d Brasil. Lei nº 12.619, de 30 de abril de 2012. Dispõe sobre o exercício da profissão de motorista; altera a Consolidação das Leis do Trabalho 
– CLT, aprovada pelo Decreto-Lei no 5.452, de 1o de maio de 1943, e as Leis nos 9.503, de 23 de setembro de 1997, 10.233, de 5 de junho 
de 2001, 11.079, de 30 de dezembro de 2004, e 12.023, de 27 de agosto de 2009, para regular e disciplinar a jornada de trabalho e o tempo 
de direção do motorista profissional; e dá outras providências. Diario Oficial Uniao. 2 maio 2012:5.
drivers, as well as the use of amphetamines in Brazil. 
The enforcement of the Brazilian Law 12,619, popularly 
known as Lei do Motorista,d may positively impact on 
the daily distance that drivers travel, their feelings of 
tiredness, their attention functioning and finally on their 
use of amphetamines. Although the data were collected 
before the implementation of Resolution 52/2011 by the 
Brazilian Agency of Health Surveillance (ANVISA), 
which banned the manufacture, importation, exportation, 
handling, prescribing and dispensing of drugs or drug 
formulations containing the substances amfepramone, 
fenproporex and mazindol, their salts, isomers and 
intermediates,d such law should also be enforced.
The effects reported here seemed to be independent of 
quality of sleep, since there was no difference between 
groups regarding performance in the PSQI.
Some limitations must be addressed: The cross-sectional 
design limited our ability to assess a causal relationship 
between amphetamine use and attention performance. 
Also, this is a pilot study, and, therefore, the sample 
size is small. The researchers are working to expand the 
sample so that future research may be able to evaluate 
the effects of drug use on attention functioning while 
controlling for confounding factors. A follow-up is 
required.
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